Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment [Microbial Immunity and Vaccines]

This article presents the proof-of-concept study for a multivalent OspA vaccine targeting a wide range of pathogenic LB Borrelia species with a single recombinant antigen for prevention of Lyme borreliosis.

http://iai.asm.org/cgi/content/short/88/4/e00917-19?rss=1

Source: Infection and Immunity - March 22, 2020 Category: Infectious Diseases Authors: Nayak, A., Schüler, W., Seidel, S., Gomez, I., Meinke, A., Comstedt, P., Lundberg, U. Tags: Microbial Immunity and Vaccines Source Type: research